Efficacy of remdesivir in a rhesus macaque model of MERS-CoV infection

被引:0
|
作者
Alexandra Le Bras
机构
[1] Lab Animal,
来源
Lab Animal | 2020年 / 49卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:150 / 150
相关论文
共 50 条
  • [1] Efficacy of remdesivir in a rhesus macaque model of MERS-CoV infection
    Le Bras, Alexandra
    LAB ANIMAL, 2020, 49 (05) : 150 - 150
  • [2] Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
    de Wit, Emmie
    Feldmann, Friederike
    Cronin, Jacqueline
    Jordan, Robert
    Okumura, Atsushi
    Thomas, Tina
    Scott, Dana
    Cihlar, Tomas
    Feldmann, Heinz
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (12) : 6771 - 6776
  • [3] MERS-CoV infection model in macaques
    Bradbury, Jane
    LANCET INFECTIOUS DISEASES, 2013, 13 (11): : 924 - 924
  • [4] Transcriptional signatures of pathogenesis and successful type I interferon and ribavirin therapy in a rhesus macaque model of MERS-CoV infection
    Rasmussen, Angela L.
    Falzarano, Darryl
    de Wit, Emmie
    Feldmann, Friederike
    Okumura, Atsushi
    Scott, Dana P.
    Brining, Douglas
    Bushmaker, Trent
    Martellaro, Cynthia
    Benecke, Arndt G.
    Munster, Vincent J.
    Feldmann, Heinz
    Katze, Michael G.
    CYTOKINE, 2013, 63 (03) : 291 - 292
  • [5] MERS-CoV Infection of Alpaca in a Region Where MERS-CoV is Endemic
    Reusken, Chantal B. E. M.
    Schilp, Chrispijn
    Raj, V. Stalin
    De Bruin, Erwin
    Kohl, Robert H. G.
    Farag, Elmoubasher A. B. A.
    Haagmans, Bart L.
    Al-Romaihi, Hamad
    Le Grange, Francois
    Bosch, Berend-Jan
    Koopmans, Marion P. G.
    EMERGING INFECTIOUS DISEASES, 2016, 22 (06) : 1129 - 1131
  • [6] MERS-CoV spike nanoparticles protect mice from MERS-CoV infection
    Coleman, Christopher M.
    Venkataraman, Thiagarajan
    Liu, Ye V.
    Glenn, Gregory M.
    Smith, Gale E.
    Flyer, David C.
    Frieman, Matthew B.
    VACCINE, 2017, 35 (12) : 1586 - 1589
  • [7] Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
    Timothy P. Sheahan
    Amy C. Sims
    Sarah R. Leist
    Alexandra Schäfer
    John Won
    Ariane J. Brown
    Stephanie A. Montgomery
    Alison Hogg
    Darius Babusis
    Michael O. Clarke
    Jamie E. Spahn
    Laura Bauer
    Scott Sellers
    Danielle Porter
    Joy Y. Feng
    Tomas Cihlar
    Robert Jordan
    Mark R. Denison
    Ralph S. Baric
    Nature Communications, 11
  • [8] Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
    Sheahan, Timothy P.
    Sims, Amy C.
    Leist, Sarah R.
    Schafer, Alexandra
    Won, John
    Brown, Ariane J.
    Montgomery, Stephanie A.
    Hogg, Alison
    Babusis, Darius
    Clarke, Michael O.
    Spahn, Jamie E.
    Bauer, Laura
    Sellers, Scott
    Porter, Danielle
    Feng, Joy Y.
    Cihlar, Tomas
    Jordan, Robert
    Denison, Mark R.
    Baric, Ralph S.
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [9] MERS-COV
    Memish, Z.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 71 - 71
  • [10] MERS-CoV
    Marcel A Müller
    BMC Infectious Diseases, 14 (Suppl 2)